» Articles » PMID: 3708390

Morphine Increases Metastatic Tumor Growth

Overview
Journal Brain Res Bull
Specialty Neurology
Date 1986 Mar 1
PMID 3708390
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Walker 256 carcinosarcoma cells produce subpleural pulmonary metastases when given intravenously to the Sprague-Dawley rat. The number of metastases increases when the rat is given morphine subsequent to the tumor load. The increase in the number of metastases can be blocked be pretreatment with the opiate antagonist naloxone. Naloxone itself does not influence the number of metastases. Pentazocine is an opiate that is agonistic to the endorphin kappa-type opiate receptor and partially antagonistic to the mu-type receptor, where morphine acts primarily. While pentazocine alone has no influence on metastases and may decrease the number when given early, pentazocine partially blocks the metastatic inducing effect of morphine.

Citing Articles

Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review.

Constance J, McFarland M, Casucci T, Deininger M, Enioutina E, Job K JMIR Res Protoc. 2023; 12:e38167.

PMID: 37213193 PMC: 10242459. DOI: 10.2196/38167.


Opium alkaloids, biosynthesis, pharmacology and association with cancer occurrence.

Vadhel A, Bashir S, Mir A, Girdhar M, Kumar D, Kumar A Open Biol. 2023; 13(5):220355.

PMID: 37132222 PMC: 10154933. DOI: 10.1098/rsob.220355.


Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.

Brinkman D, Wang J, Redmond H Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(11):1169-1178.

PMID: 30232510 DOI: 10.1007/s00210-018-1565-6.


The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells.

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V Onco Targets Ther. 2018; 11:185-191.

PMID: 29379300 PMC: 5757202. DOI: 10.2147/OTT.S145780.


Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Cao L, Li H, Lin W, Tan H, Xie L, Zhong Z Sci Rep. 2016; 6:18706.

PMID: 26729257 PMC: 4700493. DOI: 10.1038/srep18706.